Ulta Beauty grants CTO 2,933 RSUs, 3,565 options

Ulta Beauty’s Chief Technology Officer received new restricted stock units and stock options as part of equity compensation.

Rhea-AI Filing Summary

Ulta Beauty, Inc. (ULTA) reported that Chief Technology Officer Kelly E. Garcia received new equity awards. On September 1, 2026, Garcia was granted 2,933 restricted stock units, increasing direct common stock holdings to 5,083 shares after the award. Garcia also received stock options for 3,565 shares of common stock at an exercise price of $545.66 per share, expiring on September 1, 2036. The restricted stock units vest in three tranches through September 1, 2031, and the options vest in two tranches through March 15, 2029. No Rule 10b5-1 trading plan is reported for these awards.

Insider Trade Summary

Grant/Award: 6,498 shares

Grant/Award 2 txns

Insider GARCIA KELLY E

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) F2	3,565	$0.00	$0.00
Grant/Award	Common Stock F1	2,933	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 3,565 contracts (Direct); Common Stock — 5,083 shares (Direct)

Footnotes (2)

1. F1. Represents a grant of 2,933 restricted stock units, with 37.5% vesting on March 15, 2028, 37.5% vesting on March 15, 2029, and the remaining 25% vesting on September 1, 2031.
2. F2. The options, representing an initial right to purchase a total of 3,565 shares, vesting 50% on March 15, 2028 and 50% on March 15, 2029.

Key Figures

Restricted stock units granted: 2,933 units Stock options granted: 3,565 options Option exercise price: $545.66 per share +4 more

7 metrics

Restricted stock units granted 2,933 units Grant to Chief Technology Officer on September 1, 2026

Stock options granted 3,565 options Right to purchase common stock granted on September 1, 2026

Option exercise price $545.66 per share Exercise price for options on 3,565 shares

Shares held after RSU grant 5,083 shares Direct common stock holdings after September 1, 2026 award

Option expiration date September 1, 2036 Expiry of options on 3,565 shares

RSU vesting tranches 37.5%, 37.5%, 25% Vesting on March 15, 2028; March 15, 2029; and September 1, 2031

Option vesting tranches 50%, 50% Vesting on March 15, 2028 and March 15, 2029

Key Terms

restricted stock units, vesting, stock options, exercise price

4 terms

restricted stock units financial

"Represents a grant of 2,933 restricted stock units, with 37.5% vesting"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting financial

"with 37.5% vesting on March 15, 2028, 37.5% vesting on March 15, 2029"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

stock options financial

"The options, representing an initial right to purchase a total of 3,565 shares"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

exercise price financial

"right to purchase a total of 3,565 shares, vesting 50% on March 15, 2028"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

What equity awards did ULTA grant to its Chief Technology Officer on September 1, 2026?

On September 1, 2026, Ulta Beauty granted the Chief Technology Officer 2,933 restricted stock units and stock options for 3,565 shares of common stock with an exercise price of $545.66 per share, expiring on September 1, 2036.

How many ULTA shares does the Chief Technology Officer hold after these grants?

Following the September 1, 2026 grant, the Chief Technology Officer directly holds 5,083 shares of Ulta Beauty common stock. This figure reflects the reported holdings after the restricted stock unit award on that date.

What is the vesting schedule for the 2,933 ULTA restricted stock units?

The 2,933 restricted stock units vest with 37.5% on March 15, 2028, another 37.5% on March 15, 2029, and the remaining 25% on September 1, 2031, subject to the terms of the award.

How do the new ULTA stock options granted to the CTO vest?

The options to purchase 3,565 shares of Ulta Beauty common stock vest 50% on March 15, 2028 and 50% on March 15, 2029. They carry an exercise price of $545.66 per share and expire on September 1, 2036.

Were the ULTA equity awards to the Chief Technology Officer made under a Rule 10b5-1 plan?

No. The filing indicates that no Rule 10b5-1 trading plan is reported in connection with these equity awards to the Chief Technology Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 05:01 PM Accepted by SEC EDGAR 09/03/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GARCIA KELLY E

(Last) (First) (Middle)

1000 REMINGTON BLVD

SUITE 120

(Street)

BOLINGBROOK ILLINOIS 60440

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ulta Beauty, Inc. [ ULTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		A		2,933(1)	A	$0	5,083	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$545.66	09/01/2026		A		3,565		(2)	09/01/2036	Common Stock	3,565	$0	3,565	D

Explanation of Responses:

1. Represents a grant of 2,933 restricted stock units, with 37.5% vesting on March 15, 2028, 37.5% vesting on March 15, 2029, and the remaining 25% vesting on September 1, 2031.

2. The options, representing an initial right to purchase a total of 3,565 shares, vesting 50% on March 15, 2028 and 50% on March 15, 2029.

	/s/ Rene G. Casares, as attorney-in-fact for Kelly E. Garcia	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)